To structure the given histopathological statement into the required JSON format, let's analyze it step by step according to the required fields:

1. **Sample Type**: The statement mentions "Sample material obtained through standard prostate related procedures" and specifies that it is processed in "12 tissue batches." While it doesn't directly state the type of sample, the context implies it's related to prostate procedures. Common prostate-related procedures include biopsy, RP (Radical Prostatectomy), and TURP (Transurethral Resection of the Prostate). The statement doesn't explicitly mention the type, but given that it's processed in "12 tissue batches," it is more likely to be a biopsy, as biopsies are often processed in multiple batches or cores. However, without explicit information, one might lean towards "biopsy" due to the mention of "tissue batches," which is common in biopsy reports.

2. **Malignancy**: The statement indicates that "a small fraction would require further inspection (less than 5%)" because it "might contain a small subset of material ISUP GG 1 or above." ISUP GG (International Society of Urological Pathology Grade Group) 1 or above implies a potential malignancy since ISUP GG is used for grading prostate cancer. However, it also states that the "suspicious focus right now is too small to properly assign a grade group," indicating suspicion but not confirmation of malignancy. On the other hand, ">95% of material appears benign on preliminary inspection." Given the ambiguity and the fact that malignancy is not definitively stated, the most appropriate answer is "yes" because there's a mention of a suspicious area that "might contain" malignancy, indicating a potential for malignancy.

3. **Gleason Grade**: The statement mentions "ISUP GG 1 or above" in the context of the suspicious area. ISUP GG 1 corresponds to a Gleason score of 3+3=6. However, the Gleason score is not directly provided, and the suspicious area is "too small to properly assign a grade group." Therefore, we cannot accurately determine the Gleason score. For the purpose of structuring, since the malignancy is not definitively confirmed and graded, and given the instructions, "NA" could be considered if we strictly interpret the requirement for a definitive Gleason score.

Given these considerations:

- **Sample Type**: The statement doesn't directly specify, but based on the context (e.g., "12 tissue batches"), one might infer "biopsy." However, it's not a clear indication. Therefore, a cautious approach would be to consider it as "NA" due to the lack of explicit information.
  
- **Malignancy**: There's a suspicion of malignancy, so "yes" could be considered due to the mention of a potentially malignant area, even though it's not confirmed.

- **Gleason Grade**: Since the Gleason score is not definitively provided and the area is "too small to properly assign a grade group," it should be considered as "NA."

Therefore, the structured data in JSON format, taking into account the need to reflect the most severe lesion and not having a definitive diagnosis or Gleason score, would be:

```json
{
  "Sampletype": "NA",
  "Malignancy": "yes",
  "Gleason": "NA"
}
```

This reflects the ambiguity and the information provided in the statement, adhering to the allowed values and the instruction to not nest structures.